rosiglitazone has been researched along with angiogenin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, C; Friedel, M; Ho, KT; Kain, KC; Lu, Z; McDonald, CR; Mount, HT; Serghides, L; Sled, JG | 1 |
1 other study(ies) available for rosiglitazone and angiogenin
Article | Year |
---|---|
PPARĪ³ agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria.
Topics: Animals; Antimalarials; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Humans; Malaria, Cerebral; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neuroprotective Agents; PPAR gamma; Randomized Controlled Trials as Topic; Real-Time Polymerase Chain Reaction; Ribonuclease, Pancreatic; Rosiglitazone; Thiazolidinediones | 2014 |